# Lutathera PRRT Access Rests on Pharmacists

> Lutathera PRRT is being used earlier for some neuroendocrine tumor patients following the NETTER-2 trial, and pharmacists manage much of whether each dose is delivered on time. The radioactive peptide loses activity steadily after production, so late delivery or poor timing can cancel treatment.

- Date: 2026-11-16 · published 2026-11-17T12:11:20.161Z
- Category: report · region Global · magnitude low
- Page: https://feedsoft.ai/events/104869-lutathera-prrt-access-rests-on-pharmacists
- Commodities: [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

This is a medical supply and logistics story about a radiopharmaceutical with no bearing on feed ingredients, grain, oilseed or livestock prices.

## Sources

- peptide.town: https://peptide.town/story/lutathera-prrt-pharmacists-supply-timing

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.
